NYT goes to town on drug factory failings

By Nick Taylor

The New York Times has run a big feature on failings at pharmaceutical manufacturing plants. Problems at Hospira ($HSP), Ben Venue and other sterile injectable plants are dragged up as the NYT shows that it's not just compounding pharmacies that have quality issues. "In the industry, everyone knows that all of the factories are in terrible shape," an academic said. Article

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.